[Therapeutic possibilities in chronic glomerulonephritis].
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D002908:Chronic Disease; D005921:Glomerulonephritis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007213:Indomethacin / Q000627:therapeutic use*; D007668:Kidney / Q000473:pathology; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged; D010530:Peritoneal Dialysis; D011188:Potassium / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use*; D011379:Prognosis; D011507:Proteinuria / Q000628:therapy; D012640:Seizures / Q000628:therapy; D013997:Time Factors
D007166:Immunosuppressive Agents; D002699:Chlorambucil; D015122:Mercaptopurine; D001379:Azathioprine; D011188:Potassium; D011241:Prednisone; D007213:Indomethacin
Behandlungsmöglichkeiten bei der chronischen Glomerulonephritis.